PVRIG
Showing 1 - 4 of 4
Advanced Tumor Trial (PM1009 injection)
Not yet recruiting
- Advanced Tumor
- PM1009 injection
- (no location specified)
Nov 7, 2022
Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)
Recruiting
- Advanced Cancer
- +9 more
- COM701
- COM701 with Opdivo (Nivolumab).
-
Los Angeles, California
- +10 more
Jan 25, 2022
Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)
Recruiting
- Endometrial Neoplasms
- +3 more
- COM701 in combination with BMS-986207 and nivolumab.
-
Chicago, Illinois
- +8 more
Aug 8, 2022
Advanced Cancer, Ovarian Cancer, Lung Cancer Trial in United States (Dose escalation: COM902 monotherapy., Evaluation of
Recruiting
- Advanced Cancer
- +6 more
- Dose escalation: COM902 monotherapy.
- +3 more
-
Grand Rapids, Michigan
- +5 more
Aug 8, 2022